1. Home
  2. NRXP vs MTC Comparison

NRXP vs MTC Comparison

Compare NRXP & MTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NRXP
  • MTC
  • Stock Information
  • Founded
  • NRXP 2015
  • MTC 2015
  • Country
  • NRXP United States
  • MTC Hong Kong
  • Employees
  • NRXP N/A
  • MTC N/A
  • Industry
  • NRXP Biotechnology: Pharmaceutical Preparations
  • MTC Computer Software: Prepackaged Software
  • Sector
  • NRXP Health Care
  • MTC Technology
  • Exchange
  • NRXP Nasdaq
  • MTC Nasdaq
  • Market Cap
  • NRXP 58.5M
  • MTC 26.4M
  • IPO Year
  • NRXP N/A
  • MTC 2019
  • Fundamental
  • Price
  • NRXP $2.97
  • MTC $0.85
  • Analyst Decision
  • NRXP Strong Buy
  • MTC
  • Analyst Count
  • NRXP 5
  • MTC 0
  • Target Price
  • NRXP $31.40
  • MTC N/A
  • AVG Volume (30 Days)
  • NRXP 498.6K
  • MTC 739.8K
  • Earning Date
  • NRXP 11-13-2025
  • MTC 09-12-2025
  • Dividend Yield
  • NRXP N/A
  • MTC N/A
  • EPS Growth
  • NRXP N/A
  • MTC N/A
  • EPS
  • NRXP N/A
  • MTC N/A
  • Revenue
  • NRXP N/A
  • MTC $2,675,833.00
  • Revenue This Year
  • NRXP N/A
  • MTC N/A
  • Revenue Next Year
  • NRXP $231.16
  • MTC N/A
  • P/E Ratio
  • NRXP N/A
  • MTC N/A
  • Revenue Growth
  • NRXP N/A
  • MTC 114.77
  • 52 Week Low
  • NRXP $1.10
  • MTC $0.76
  • 52 Week High
  • NRXP $6.01
  • MTC $6.42
  • Technical
  • Relative Strength Index (RSI)
  • NRXP 54.61
  • MTC 42.88
  • Support Level
  • NRXP $2.73
  • MTC $0.78
  • Resistance Level
  • NRXP $3.18
  • MTC $1.80
  • Average True Range (ATR)
  • NRXP 0.24
  • MTC 0.13
  • MACD
  • NRXP 0.04
  • MTC -0.01
  • Stochastic Oscillator
  • NRXP 71.04
  • MTC 7.14

About NRXP NRX Pharmaceuticals Inc.

NRX Pharmaceuticals Inc is a clinical-stage, small-molecule pharmaceutical company that develops and plans to distribute novel therapeutics for the treatment of central nervous system disorders and life-threatening pulmonary diseases. It has announced the commercialization of ZYESAMI (Aviptadil), an application for COVID-related respiratory failure. The company is also developing NRX-100/101, the first sequential drug regimen for bipolar depression in patients with acute suicidal ideation and behavior.

About MTC MMTec Inc.

MMTEC Inc provides Internet-based technology services and solutions to the Chinese language speaking hedge funds, mutual funds, registered investment advisors, proprietary trading groups, and brokerage firms engaging in securities market transactions and settlements globally. It offers complete suite trading solutions, including services such as fund establishment, issuance, custody, transaction, and settlement. The Company currently has two operating segments, Gujia, MM Future, HC Securities, and MM Global. It generates maximum revenue from the Gujia segment. Gujia segment provides market data services and investor relations management services to customers in China.

Share on Social Networks: